Guardant Health’s Shield™ blood test receives US FDA Approval Guardant Health AMEA 159 подписчиков Скачать
Indian doctors share how liquid biopsies guide treatment decisions across the cancer care continuum Скачать
Leading Medical Oncologists Sharing Why Liquid Biopsies are a Solid Alternative to Tissue Genotyping Скачать
Expert Opinion | Dr. Clara Montagut | The challenges in detecting MRD in localized colon cancer Скачать
Expert Opinion | Dr. Nir Peled | Liquid biopsy as a first line diagnostic tool for NSCLC patients Скачать
Expert Opinion | Dr. Amit Rauthan | Benefits of using the plasma-first approach for NSCLC patients Скачать
Prof. Arkenau speaks about using Guardant360® for patients with advanced gastrointestinal cancer. Скачать
How can liquid biopsies like Guardant360®️ help guide treatment decisions for advanced stage cancer? Скачать
Guardant Health AMEA Wins Oncology Product Innovation of the Year at Healthcare Asia Medtech Awards Скачать
Oncologist talks about using liquid biopsies like the Guardant360® test to guide treatment decisions Скачать
Guardant360® test results show more than 90% agreement with tissue (Findings from NILE Study) Скачать
PENN2 Study findings: Liquid biopsies like Guardant360® are changing the face of precision oncology. Скачать
